MedPath

Effects of Dietary Nitrate in Hypertensive Pregnant Women

Not Applicable
Completed
Conditions
Pregnancy
Hypertension
Interventions
Dietary Supplement: Beetroot juice
Dietary Supplement: Nitrate-depleted beetroot juice
Registration Number
NCT02520687
Lead Sponsor
University of Manchester
Brief Summary

High blood pressure in pregnancy affects around 10% of pregnancies, and is associated with serious adverse outcomes for both mother and baby. Treatment options for the management of high blood pressure in pregnancy are currently limited. Studies in non-pregnant individuals have shown that supplementation with dietary nitrate, using beetroot juice, can significantly lower blood pressure and improve blood flow. This study aims to investigate whether supplementation with dietary nitrate (via beetroot juice) can improve blood pressure regulation in pregnant women with chronic high blood pressure, and will also determine whether this can improve blood flow across the placenta.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
44
Inclusion Criteria
  • Women diagnosed with chronic hypertension (systolic blood pressure of 130-144 mmHg and/or diastolic blood pressure of 80-94 mmHg).
  • Between 22 - 35+6 weeks gestation
Exclusion Criteria
  • Multi-fetal pregnancy
  • Currently taking anti-hypertensive medication
  • Pre-existing diabetes (Type 1 or Type 2)
  • Lacking ability to consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dietary nitrate, beetroot juiceBeetroot juiceOnce daily 70mL dose of beetroot juice, containing 400mg inorganic nitrate, for 7 consecutive days.
Nitrate-depleted beetroot juiceNitrate-depleted beetroot juiceOnce daily 70mL dose of beetroot juice, depleted of nitrate, for 7 consecutive days.
Primary Outcome Measures
NameTimeMethod
Change in clinic blood pressure (compared to baseline) between treatment and placebo groupsThe outcome will be determined after 7 days treatment (compared to baseline)
Secondary Outcome Measures
NameTimeMethod
Recruitment ratesAcross study (18 months)
Uterine artery blood flow (compared to baseline)The outcome will be determined after 7 days treatment (compared to baseline)
Umbilical artery blood flow (compared to baseline)The outcome will be determined after 7 days treatment (compared to baseline)
Changes in plasma and salivary nitrate concentrationsThe outcome will be determined after 7 days treatment (compared to baseline)
Changes in plasma and salivary nitrite concentrationsThe outcome will be determined after 7 days treatment (compared to baseline)

Trial Locations

Locations (1)

Maternal and Fetal Health Research Centre

🇬🇧

Manchester, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath